Resonance Health Limited (ASX:RHT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0400
-0.0010 (-2.44%)
Jul 2, 2025, 2:38 PM AEST
-32.20%
Market Cap 18.84M
Revenue (ttm) 10.53M
Net Income (ttm) -309.34K
Shares Out 459.62M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 157,159
Average Volume 155,559
Open 0.0400
Previous Close 0.0410
Day's Range 0.0390 - 0.0400
52-Week Range 0.0340 - 0.0680
Beta 1.10
RSI 56.70
Earnings Date Aug 29, 2025

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in Australia, the Asia Pacific, North America, Europe, the Middle East, and Africa. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; HepaFa... [Read more]

Sector Healthcare
Founded 1987
Employees 16
Stock Exchange Australian Securities Exchange
Ticker Symbol RHT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.